论文信息 - First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial - 字舞流文

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial

D. Rizopoulos | V. Wolters | P. V. van Rheenen | J. Stapelbroek | K. Kolho | T. D. de Meij | M. Doukas | M. Aardoom | T. Hummel | J. Samsom | J. Escher | O. Norbruis | L. de Ridder | M. Cozijnsen | H. V. van Wering | M. Groeneweg | I. Hojsak | M. Schreurs | M. V. van Wijk | S. Teklenburg-Roord | C. van der Feen | M. Jongsma | M. van Pieterson | Sarah T A Teklenburg-Roord